nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1–3 clinical trials: A Children’s Cancer and Leukaemia Group (CCLG) study
|
Messahel, Boo |
|
2009 |
45 |
5 |
p. 819-826 8 p. |
artikel |
2 |
Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor
|
Kong, Dexin |
|
2009 |
45 |
5 |
p. 857-865 9 p. |
artikel |
3 |
A phase I and pharmacokinetic study of daily oral cediranib, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer: A study of the National Cancer Institute of Canada Clinical Trials Group
|
Goss, Glenwood |
|
2009 |
45 |
5 |
p. 782-788 7 p. |
artikel |
4 |
Calendar
|
|
|
2009 |
45 |
5 |
p. I-IV nvt p. |
artikel |
5 |
Corrigendum to ‘Molecular basis for the development of novel taxanes in the treatment of metastatic breast cancer’ [EJC Supplement 6 (10) (2008) 3–11]
|
Aapro, Matti S. |
|
2009 |
45 |
5 |
p. 899- 1 p. |
artikel |
6 |
Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography
|
Duijm, Lucien E.M. |
|
2009 |
45 |
5 |
p. 774-781 8 p. |
artikel |
7 |
Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers?
|
Jakubowska, Anna |
|
2009 |
45 |
5 |
p. 837-842 6 p. |
artikel |
8 |
Editorial board
|
|
|
2009 |
45 |
5 |
p. ii- 1 p. |
artikel |
9 |
Effectiveness of immediate preoperative injection of radiopharmaceutical and blue dye for sentinel node biopsy in patients with breast cancer
|
Dixon, J.M. |
|
2009 |
45 |
5 |
p. 795-799 5 p. |
artikel |
10 |
Effect of HIF-1 modulation on the response of two- and three-dimensional cultures of human colon cancer cells to 5-fluorouracil
|
Ravizza, Raffaella |
|
2009 |
45 |
5 |
p. 890-898 9 p. |
artikel |
11 |
EJC NEWS, ISSUE 5, 2009
|
|
|
2009 |
45 |
5 |
p. 723-727 5 p. |
artikel |
12 |
EORTC-GU group expert opinion on metastatic renal cell cancer
|
de Reijke, Theo M. |
|
2009 |
45 |
5 |
p. 765-773 9 p. |
artikel |
13 |
Evaluation of data quality in the cancer registry: Principles and methods. Part I: Comparability, validity and timeliness
|
Bray, Freddie |
|
2009 |
45 |
5 |
p. 747-755 9 p. |
artikel |
14 |
Evaluation of data quality in the cancer registry: Principles and methods Part II. Completeness
|
Parkin, D. Max |
|
2009 |
45 |
5 |
p. 756-764 9 p. |
artikel |
15 |
Frequency of the mitochondrial DNA 4977bp deletion in oesophageal mucosa during the progression of Barrett’s oesophagus
|
Tan, Benjamin H.L. |
|
2009 |
45 |
5 |
p. 736-740 5 p. |
artikel |
16 |
Improving the efficiency of a chemotherapy day unit: Applying a business approach to oncology
|
van Lent, Wineke A.M. |
|
2009 |
45 |
5 |
p. 800-806 7 p. |
artikel |
17 |
Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: A mechanism of lymphangiogenesis in lung cancer
|
Ming, Jian |
|
2009 |
45 |
5 |
p. 866-873 8 p. |
artikel |
18 |
Internal mammary sentinel nodes: Ignore, irradiate or operate?
|
Coombs, Nathan J. |
|
2009 |
45 |
5 |
p. 789-794 6 p. |
artikel |
19 |
Molecular prediction of early recurrence after resection of hepatocellular carcinoma
|
Yoshioka, Shinichi |
|
2009 |
45 |
5 |
p. 881-889 9 p. |
artikel |
20 |
Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: The CORGI-L study
|
Gunnlaugsson, Adalsteinn |
|
2009 |
45 |
5 |
p. 807-813 7 p. |
artikel |
21 |
Phase 0 clinical trials: Recommendations from the task force on methodology for the development of innovative cancer therapies
|
Kummar, Shivaani |
|
2009 |
45 |
5 |
p. 741-746 6 p. |
artikel |
22 |
Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma
|
Martín-Algarra, Salvador |
|
2009 |
45 |
5 |
p. 732-735 4 p. |
artikel |
23 |
Phase 0 (zero) clinical trials: More than zero benefit?
|
Schellens, Jan H.M. |
|
2009 |
45 |
5 |
p. 728-729 2 p. |
artikel |
24 |
Shorter fractionation schedules in breast cancer radiotherapy: Clinical and economic implications
|
Mannino, Mariella |
|
2009 |
45 |
5 |
p. 730-731 2 p. |
artikel |
25 |
Testicular function of survivors of childhood cancer: A comparative study between ifosfamide- and cyclophosphamide-based regimens
|
Ridola, Vita |
|
2009 |
45 |
5 |
p. 814-818 5 p. |
artikel |
26 |
The launch of Cancer Research UK’s ‘Reduce the Risk’ campaign: Baseline measurements of public awareness of cancer risk factors in 2004
|
Redeker, Claudia |
|
2009 |
45 |
5 |
p. 827-836 10 p. |
artikel |
27 |
Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age
|
van de Nieuwenhof, Hedwig P. |
|
2009 |
45 |
5 |
p. 851-856 6 p. |
artikel |
28 |
Wilms’ tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells
|
Glienke, Wolfgang |
|
2009 |
45 |
5 |
p. 874-880 7 p. |
artikel |
29 |
Wine, liquor, beer and risk of breast cancer in a large population
|
Li, Yan |
|
2009 |
45 |
5 |
p. 843-850 8 p. |
artikel |